In outer tissues, GLP-1RAs enhance hepatic lipid metabolic process by reducing hepatic steatosis and circulating lipid levels. They also protect kidney function by reducing albuminuria and slowing down the decrease in estimated glomerular filtration price (eGFR). In the 1990s, Knudsen used her training in molecular pharmacology at Novo Nordisk to get rid of the quick
